Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Market growth influenced due to following factors-

  • Rise in government funding, growth in the number of genomics projects.
  • High prevalence of infectious diseases and cancer.
  • Technological advancements, increasing production of genetically modified crops, and growing application areas of genomics.

Global market size-

According to research report the global Genome Editing Market is projected to reach $6.28 billion by 2022, at a CAGR of 14.5% during the forecast period.

Leading Players

The major companies in the Genome Engineering Genome Editing Market include Thermo Fisher Scientific (US), Merck (Germany), Horizon Discovery Limited UK, Lonza (Switzerland), GenScript (US), Eurofins Scientific (Luxembourg), and Sangamo Therapeutics (US). 

Top Segments-

The CRISPR technology segment accounted for the largest share of the genome editing/genome engineering industry in 2019. The large share of this segment can be attributed to the ease of use associated with CRISPR, which gives it a significant advantage over ZFN and TALEN. Another potential advantage is its ability to multiplex.

Based on application, the genome editing/genome engineering market is segmented into cell line engineering, genetic engineering, diagnostic applications, drug discovery & development, and other applications. A number of factors, such as the increased funding from governments and private organizations, growing industry focus on stem cell research, and global awareness are driving market growth in this segment.

For More Details, Download PDF Brochure

Geographic Overview –

The Genome Engineering Genome Editing Market is divided into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share of the global genome editing/genome engineering market, closely followed by Europe. The large share of North America can be attributed to factors such as the development of gene therapy in the US, the increasing use of genetically modified crops, the rising prevalence of infectious diseases and cancer, and the availability of research grants and funding. 

Login

Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe